Table 1.
Glial tumor patients' clinical and molecular data. In the table are reported the age and gender of each patient, the number of days from the diagnosis to the time of the last follow up, the prognosis at the time of the last follow-up, and the molecular findings. Empty boxes correspond to those cases in which the biomarker was not tested.
| Patients' clinical & molecular data | ||||||||
|---|---|---|---|---|---|---|---|---|
| Oligodendroglioma (WHO gr2) | Age | Sex | Time to follow up | Status | IDH 1 | ATRX | 1p19q | Integrated diagnosis |
| 1 | 57 | M | 2225 | DEAD | 1 | 1 | Astrocytoma,IDH mutant | |
| 2 | 47 | M | 4697 | ALIVE | 1 | 0 | Oligodendroglioma,IDH mutant, NOS | |
| 3 | 39 | F | 4725 | ALIVE | 1 | 0 | 1 | Oligodendroglioma,IDH mutant, 1p19q codeleted |
| 4 | 31 | M | 3907 | ALIVE | 1 | 1 | Oligodendroglioma,IDH mutant, NOS | |
| 5 | 47 | F | 3182 | ALIVE | 1 | 1 | Astrocytoma,IDH mutant | |
| 6 | 39 | F | 3354 | ALIVE | 1 | 1 | Oligodendroglioma,IDH mutant, 1p19q codeleted | |
| 7 | 48 | F | 3001 | ALIVE | 1 | 1 | Oligodendroglioma,IDH mutant, 1p19q codeleted | |
| 8 | 62 | F | 1687 | DEAD | 1 | 1 | Oligodendroglioma,IDH mutant, 1p19q codeleted | |
| 9 | 74 | M | 1242 | DEAD | 1 | 1 | Oligodendroglioma,IDH mutant, 1p19q codeleted | |
| Astrocytoma (WHO gr2) |
Age | Sex | Time to follow up | Status | IDH 1 | ATRX | 1p19q | Integrated diagnosis |
| 1 | 48 | F | 537 | DEAD | 0 | 0 | Astrocytoma, NOT IDH mutant R132H | |
| 2 | 33 | M | 2216 | DEAD | NA | NA | Astrocytoma, NOS | |
| 3 | 29 | F | 4109 | ALIVE | 0 | 0 | Astrocytoma, NOT IDH mutant R132H | |
| 4 | 34 | M | 4565 | DEAD | 1 | 1 | Astrocytoma, IDH mutant | |
| 5 | 31 | F | 4151 | ALIVE | 1 | 0 | Astrocytoma, IDH mutant,NOS | |
| 6 | 46 | M | 3133 | ALIVE | 1 | 1 | Oligodendroglioma, IDH mutant, 1p/19q codeleted | |
| 7 | 42 | F | 3211 | ALIVE | 1 | 1 | Oligodendroglioma, IDH mutant, 1p/19q codeleted | |
| 8 | 47 | M | 2285 | ALIVE | 1 | 1 | Astrocytoma, IDH mutant | |
| 9 | 48 | F | 2250 | ALIVE | 0 | 0 | Astrocytoma, NOT IDH mutant R132H | |
| GBM (WHO gr4) |
Age | Sex | Time to follow up | Status | IDH 1 | ATRX | 1p19q | Integrated diagnosis |
| 1 | 37 | M | 3076 | ALIVE | 1 | 1 | GBM, IDH mutant | |
| 2 | 57 | M | 537 | DEAD | 0 | GBM, NOT IDH mutant R132H | ||
| 3 | 59 | M | 212 | DEAD | 0 | GBM, NOT IDH mutant R132H | ||
| 4 | 59 | F | 2297 | DEAD | 0 | GBM, NOT IDH mutant R132H | ||
| 5 | 57 | M | 4 | DEAD | 0 | GBM, NOT IDH mutant R132H | ||
| 6 | 63 | F | 247 | DEAD | 0 | GBM, NOT IDH mutant R132H | ||
| 7 | 77 | M | 136 | DEAD | 0 | GBM, NOT IDH mutant R132H | ||
| 8 | 65 | M | 386 | DEAD | 0 | GBM, NOT IDH mutant R132H | ||
| 9 | 43 | F | 247 | DEAD | 0 | GBM, NOT IDH mutant R132H | ||
| 10 | 46 | M | 392 | DEAD | 0 | GBM, NOT IDH mutant R132H | ||